These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 1445385)

  • 21. Anticoagulant versus amidolytic activity of tissue factor pathway inhibitor in coronary artery disease.
    Mukherjee M; Ranlall N; Patel G; Rutlin A; Jehanli A; Kakkar VV
    Blood Coagul Fibrinolysis; 2000 Apr; 11(3):285-91. PubMed ID: 10870809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of rare earth compounds on human peripheral mononuclear cell telomerase and apoptosis].
    Yu L; Dai YC; Yuan ZK; Li J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Jul; 38(4):248-51. PubMed ID: 15312584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DX-9065a, a new synthetic, potent anticoagulant and selective inhibitor for factor Xa.
    Hara T; Yokoyama A; Ishihara H; Yokoyama Y; Nagahara T; Iwamoto M
    Thromb Haemost; 1994 Mar; 71(3):314-9. PubMed ID: 8029795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SSR182289A, a novel, orally active thrombin inhibitor: in vitro profile and ex vivo anticoagulant activity.
    Berry CN; Lassalle G; Lunven C; Altenburger JM; Guilbert F; Lalé A; Hérault JP; Lecoffre C; Pfersdorff C; Herbert JM; O'Connor SE
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1189-98. PubMed ID: 12438543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP; Bernat A; Gaich C; Herbert M
    Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor.
    Rupin A; Mennecier P; Lila C; de Nanteuil G; Verbeuren TJ
    Thromb Haemost; 1997 Oct; 78(4):1221-7. PubMed ID: 9364988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of factor XI in a dilute thromboplastin assay of extrinsic coagulation pathway.
    He R; Xiong S; He X; Liu F; Han J; Li J; He S
    Thromb Haemost; 2001 Jun; 85(6):1055-9. PubMed ID: 11434684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The potencial role of rare earths in the pathogenesis of interstitial lung disease: a case report of movie projectionist as investigated by neutron activation analysis.
    Porru S; Placidi D; Quarta C; Sabbioni E; Pietra R; Fortaner S
    J Trace Elem Med Biol; 2001 Apr; 14(4):232-6. PubMed ID: 11396783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel anticoagulants based on direct inhibition of thrombin and factor Xa.
    Gardell SJ; Sanderson PE
    Coron Artery Dis; 1998; 9(2-3):75-81. PubMed ID: 9647407
    [No Abstract]   [Full Text] [Related]  

  • 30. Anticoagulant property of a semi-synthesized sodium beta-1,4-glucan sulfate.
    Wang ZM; Li L; Li B; Guo SY
    Yao Xue Xue Bao; 2006 Apr; 41(4):323-7. PubMed ID: 16856476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticoagulant properties of extracellular slime substance produced by Staphylococcus epidermidis.
    Bykowska K; Ludwicka A; Wegrzynowicz Z; Lopaciuk S; Kopeć M
    Thromb Haemost; 1985 Dec; 54(4):853-6. PubMed ID: 4089818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experience with chromogenic substrates in studies of clotting and fibrinolytic systems.
    Chmielewska J; Latallo ZS
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):111-4. PubMed ID: 6177591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two new groups of homoleptic rare earth pyridylbenzimidazolates: (NC12H8(NH)2)[Ln(N3C12H8)4] with Ln = Y, Tb, Yb, and [Ln(N3C12H8)2(N3C12H9)2][Ln(N3C12H8)4](N3C12H9)2 with Ln = La, Sm, Eu.
    Müller-Buschbaum K; Quitmann CC
    Inorg Chem; 2003 Apr; 42(8):2742-50. PubMed ID: 12691584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and anticoagulation activity of sodium cellulose sulfate.
    Wang ZM; Li L; Zheng BS; Normakhamatov N; Guo SY
    Int J Biol Macromol; 2007 Oct; 41(4):376-82. PubMed ID: 17602735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin chain-length dependence of factor Xa inhibition by antithrombin in plasma.
    Rezaie AR
    Thromb Res; 2007; 119(4):481-8. PubMed ID: 16515805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative toxicity of stable rare earth compounds. II. Effect of citrate and edetate complexing on acute toxicity in mice and guinea pigs.
    GRACA JG; DAVISON FC; FEAVEL JB
    Arch Environ Health; 1962 Nov; 5():437-44. PubMed ID: 13949687
    [No Abstract]   [Full Text] [Related]  

  • 37. Rare earth elements and hypertension risk among housewives: A pilot study in Shanxi Province, China.
    Wang B; Yan L; Huo W; Lu Q; Cheng Z; Zhang J; Li Z
    Environ Pollut; 2017 Jan; 220(Pt B):837-842. PubMed ID: 27816296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rare-earth oxide nanostructures: rules of rare-earth nitrate thermolysis in octadecylamine.
    Wang D; Wang Z; Zhao P; Zheng W; Peng Q; Liu L; Chen X; Li Y
    Chem Asian J; 2010 Apr; 5(4):925-31. PubMed ID: 20148431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. THE ACUTE MAMMALIAN TOXICITY OF RARE EARTH NITRATES AND OXIDES.
    BRUCE DW; HIETBRINK BE; DUBOIS KP
    Toxicol Appl Pharmacol; 1963 Nov; 5():750-9. PubMed ID: 14082480
    [No Abstract]   [Full Text] [Related]  

  • 40. Distribution Characteristics of Rare Earth Elements and Selenium in Hair of Centenarians Living in China Longevity Region.
    Zhang R; Wang L; Li Y; Li H; Xu Y
    Biol Trace Elem Res; 2020 Sep; 197(1):15-24. PubMed ID: 31728813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.